| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7368469 | KING PFIZER | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
Aug, 2020
(3 years ago) | |
Altace is owned by King Pfizer.
Altace contains Ramipril.
Altace has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Altace are:
- US7368469
Altace was authorised for market use on 27 February, 2007.
Altace is available in tablet;oral dosage forms.
Altace can be used as method of reducing risk of myocardial infarction, stroke and death.
The generics of Altace are possible to be released after 30 August, 2020.
Drugs and Companies using RAMIPRIL ingredient
Market Authorisation Date: 27 February, 2007
Treatment: Method of reducing risk of myocardial infarction, stroke and death
Dosage: TABLET;ORAL
ALTACE family patents
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7368469 | KING PHARMS LLC | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events |
Aug, 2020
(3 years ago) | |
Altace is owned by King Pharms Llc.
Altace contains Ramipril.
Altace has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Altace are:
- US7368469
Altace was authorised for market use on 28 January, 1991.
Altace is available in capsule;oral dosage forms.
Altace can be used as method of reducing risk of myocardial infarction, stroke and death.
The generics of Altace are possible to be released after 30 August, 2020.
Drugs and Companies using RAMIPRIL ingredient
Market Authorisation Date: 28 January, 1991
Treatment: Method of reducing risk of myocardial infarction, stroke and death
Dosage: CAPSULE;ORAL
ALTACE family patents